Purple Drank Prevalence and Characteristics of Misusers of Codeine Cough Syrup Mixtures" Addictive Behaviors 38 Pp
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
EL PASO INTELLIGENCE CENTER DRUG TREND Synthetic Stimulants Marketed As Bath Salts
LAW ENFORCEMENT SENSITIVE EPIC Tactical Intelligence Bulletins EL PASO INTELLIGENCE CENTER DRUG TREND TACTICAL INTELLIGENCE BULLETIN EB11-16 ● Synthetic Stimulants Marketed as Bath Salts ● March 8, 2011 This document is the property of the Drug Enforcement Administration (DEA) and is marked Law Enforcement Sensitive (LES). Further dissemination of this document is strictly forbidden except to other law enforcement agencies for criminal law enforcement purposes. The following information must be handled and protected accordingly. Summary Across the United States, synthetic stimulants that are sold as “bath salts”¹ have become a serious drug abuse threat. These products are produced under a variety of faux brand names, and they are indirectly marketed as legal alternatives to cocaine, amphetamine, and Ecstasy (MDMA or 3,4-Methylenedioxymethamphetamine). Poison control centers nationwide have received hundreds of calls related to the side-effects of, and overdoses from, the use of these potent and unpredictable products. Numerous media reports have cited bath salt stimulant overdose incidents that have resulted in emergency room visits, hospitalizations, and severe psychotic episodes, some of which, have led to violent outbursts, self-inflicted wounds, and even suicides. A number of states have imposed emergency measures to ban bath salt stimulant products (or the chemicals in them) including Florida, Louisiana, North Dakota, and West Virginia; and similar measures are pending in Hawaii, Kentucky, Michigan, and Mississippi. A prominent U.S. -
The Nursing Implications of Bath Salts Abuse: a Learning Tool and Curriculum for Emergency
James Madison University JMU Scholarly Commons Senior Honors Projects, 2010-current Honors College Spring 2014 The ursinn g implications of bath salts abuse: A learning tool and curriculum for emergency department nurses Molly Ann Brennan James Madison University Follow this and additional works at: https://commons.lib.jmu.edu/honors201019 Recommended Citation Brennan, Molly Ann, "The urn sing implications of bath salts abuse: A learning tool and curriculum for emergency department nurses" (2014). Senior Honors Projects, 2010-current. 390. https://commons.lib.jmu.edu/honors201019/390 This Thesis is brought to you for free and open access by the Honors College at JMU Scholarly Commons. It has been accepted for inclusion in Senior Honors Projects, 2010-current by an authorized administrator of JMU Scholarly Commons. For more information, please contact [email protected]. The Nursing Implications of Bath Salts Abuse: A Learning Tool and Curriculum for Emergency Department Nurses _______________________ A Project Presented to the Faculty of the Undergraduate College of Health and Behavioral Studies James Madison University _______________________ in Partial Fulfillment of the Requirements for the Degree of Bachelor of Science in Nursing _______________________ by Molly Ann Brennan May, 2014 Accepted by the faculty of the Department of Nursing, James Madison University, in partial fulfillment of the requirements for the Degree of Bachelor of Science in Nursing. FACULTY COMMITTEE: HONORS PROGRAM APPROVAL: Project Advisor: Annie Horigan, Ph.D., -
Concurrent Alcohol and Tobacco Dependence
Concurrent Alcohol and Tobacco Dependence Mechanisms and Treatment David J. Drobes, Ph.D. People who drink alcohol often also smoke and vice versa. Several mechanisms may contribute to concurrent alcohol and tobacco use. These mechanisms include genes that are involved in regulating certain brain chemical systems; neurobiological mechanisms, such as cross-tolerance and cross-sensitization to both drugs; conditioning mechanisms, in which cravings for alcohol or nicotine are elicited by certain environmental cues; and psychosocial factors (e.g., personality characteristics and coexisting psychiatric disorders). Treatment outcomes for patients addicted to both alcohol and nicotine are generally worse than for people addicted to only one drug, and many treatment providers do not promote smoking cessation during alcoholism treatment. Recent findings suggest, however, that concurrent treatment for both addictions may improve treatment outcomes. KEY WORDS: comorbidity; AODD (alcohol and other drug dependence); alcoholic beverage; tobacco in any form; nicotine; smoking; genetic linkage; cross-tolerance; AOD (alcohol and other drug) sensitivity; neurotransmitters; brain reward pathway; cue reactivity; social AODU (AOD use); cessation of AODU; treatment outcome; combined modality therapy; literature review lcohol consumption and tobacco ers who are dependent on nicotine Department of Health and Human use are closely linked behaviors. have a 2.7 times greater risk of becoming Services 1989). The concurrent use of A Thus, not only are people who alcohol dependent than nonsmokers both drugs by pregnant women can drink alcohol more likely to smoke (and (e.g., Breslau 1995). Finally, although also result in more severe prenatal dam- vice versa) but also people who drink the smoking rate in the general popula age and neurocognitive deficits in their larger amounts of alcohol tend to smoke tion has gradually declined over the offspring than use of either drug alone more cigarettes. -
Medications to Treat Opioid Use Disorder Research Report
Research Report Revised Junio 2018 Medications to Treat Opioid Use Disorder Research Report Table of Contents Medications to Treat Opioid Use Disorder Research Report Overview How do medications to treat opioid use disorder work? How effective are medications to treat opioid use disorder? What are misconceptions about maintenance treatment? What is the treatment need versus the diversion risk for opioid use disorder treatment? What is the impact of medication for opioid use disorder treatment on HIV/HCV outcomes? How is opioid use disorder treated in the criminal justice system? Is medication to treat opioid use disorder available in the military? What treatment is available for pregnant mothers and their babies? How much does opioid treatment cost? Is naloxone accessible? References Page 1 Medications to Treat Opioid Use Disorder Research Report Discusses effective medications used to treat opioid use disorders: methadone, buprenorphine, and naltrexone. Overview An estimated 1.4 million people in the United States had a substance use disorder related to prescription opioids in 2019.1 However, only a fraction of people with prescription opioid use disorders receive tailored treatment (22 percent in 2019).1 Overdose deaths involving prescription opioids more than quadrupled from 1999 through 2016 followed by significant declines reported in both 2018 and 2019.2,3 Besides overdose, consequences of the opioid crisis include a rising incidence of infants born dependent on opioids because their mothers used these substances during pregnancy4,5 and increased spread of infectious diseases, including HIV and hepatitis C (HCV), as was seen in 2015 in southern Indiana.6 Effective prevention and treatment strategies exist for opioid misuse and use disorder but are highly underutilized across the United States. -
The Opioid Epidemic: What Labs Have to Do with It?
The Opioid Epidemic: What labs have to do with it? Ewa King, Ph.D. Associate Director of Health RIDOH State Health Laboratories Analysis. Answers. Action. www.aphl.org Overview • Overdose trends • Opioids and their effects • Analytical testing approaches • Toxicology laboratories Analysis. Answers. Action. www.aphl.org Opioid overdose crisis 1 Analysis. Answers. Action. www.aphl.org Opioid overdose crisis 2 Analysis. Answers. Action. www.aphl.org Opiates and Opioids • Opiates vs. Opioids • Opiates: Naturally occurring, derived from the poppy plant • Opioids: “Opiate-like” drugs in effects, not chemical structure Includes opiates • Narcotic analgesics • CNS depressants • DEA Schedule I or II controlled substances • Additive effect with other CNS depressant drugs Analysis. Answers. Action. www.aphl.org Efficacy of Opioids • How do opioids work? • Bind with opioid receptors • Brain, spinal cord, GI tract, and throughout the body • Pain, emotion, breathing, movement, and digestion Opioid Receptor Analysis. Answers. Action. www.aphl.org Effects of Opioids Physiological Psychological • Pain relief • Drowsiness/ sedation • Cough suppression • Mental confusion • GI motility • Loss of memory • Respiratory depression • Lethargy/ apathy • Pupillary constriction • Euphoria/ tranquility • Itching • Mood swings • Constipation • Depression • Dependence • Withdrawal • Dependence Analysis. Answers. Action. www.aphl.org Opiates 1 Opiates • Naturally occurring alkaloids Opium • Latex from the opium poppy plant Codeine: • Mild to moderate pain • Antitussive Morphine: • Severe pain • Metabolite of codeine and heroin Analysis. Answers. Action. www.aphl.org Opiates 2 Semi-synthetic Opiates: • Synthesized from a natural opiate Heroin: • Schedule I narcotic Hydrocodone (Vicodin): • Mild to moderate pain • Metabolizes to hydromorphone (Dilaudid) Oxycodone (Oxycontin/Percocet): • Moderate to severe pain • Metabolizes to oxymorphone (Opana) Analysis. Answers. Action. -
Adverse Reactions to Hallucinogenic Drugs. 1Rnstttutton National Test
DOCUMENT RESUME ED 034 696 SE 007 743 AUTROP Meyer, Roger E. , Fd. TITLE Adverse Reactions to Hallucinogenic Drugs. 1rNSTTTUTTON National Test. of Mental Health (DHEW), Bethesda, Md. PUB DATP Sep 67 NOTE 118p.; Conference held at the National Institute of Mental Health, Chevy Chase, Maryland, September 29, 1967 AVATLABLE FROM Superintendent of Documents, Government Printing Office, Washington, D. C. 20402 ($1.25). FDPS PRICE FDPS Price MFc0.50 HC Not Available from EDRS. DESCPTPTOPS Conference Reports, *Drug Abuse, Health Education, *Lysergic Acid Diethylamide, *Medical Research, *Mental Health IDENTIFIEPS Hallucinogenic Drugs ABSTPACT This reports a conference of psychologists, psychiatrists, geneticists and others concerned with the biological and psychological effects of lysergic acid diethylamide and other hallucinogenic drugs. Clinical data are presented on adverse drug reactions. The difficulty of determining the causes of adverse reactions is discussed, as are different methods of therapy. Data are also presented on the psychological and physiolcgical effects of L.S.D. given as a treatment under controlled medical conditions. Possible genetic effects of L.S.D. and other drugs are discussed on the basis of data from laboratory animals and humans. Also discussed are needs for futher research. The necessity to aviod scare techniques in disseminating information about drugs is emphasized. An aprentlix includes seven background papers reprinted from professional journals, and a bibliography of current articles on the possible genetic effects of drugs. (EB) National Clearinghouse for Mental Health Information VA-w. Alb alb !bAm I.S. MOMS Of NAM MON tMAN IONE Of NMI 105 NUNN NU IN WINES UAWAS RCM NIN 01 NUN N ONMININI 01011110 0. -
Polydrug Use Factsheet
WHAT YOU NEED TO KNOW ABOUT MIXING DRUGS WHAT IS POLYDRUG USE? Polydrug use is the mixing of different drugs, or taking one drug while under the influence (or experiencing the after-effects) of another drug. Polydrug use can include alcohol, prescribed medications and/or illegal drugs. Combining drugs carries extra risks and can be extremely dangerous. The more drugs a person takes (or is affected by) at a time, the more chance there is of something going wrong. WHY DO PEOPLE MIX DRUGS? There are several reasons people mix drugs, for example: • In an attempt to increase the effect of another drug or to ‘bring on’ its desired effects. For example, sometimes people smoke cigarettes to enhance their experience on ecstasy, or drink alcohol when they’re also under the influence of cocaine • In an attempt to reduce the negative effects of a drug, usually when ‘coming down’ from that drug. For instance, some people use cannabis or take a sleeping pill after they have used ecstasy • To substitute for the drug they were really looking for, ‘the next best thing’ • It seemed like a ‘good idea at the time’. Sometimes people will mix drugs when they are already intoxicated, aren’t thinking straight or if people around them are mixing drugs Sometimes people who are trying to cut down their use of one drug find that they start to use more of another drug to help manage withdrawal symptoms (the unpleasant effects that occur when stopping drug use). For example, someone trying to stop using methamphetamine or cannabis might start to drink more alcohol to try and relax or sleep if they are feeling anxious, stressed or are unable to sleep. -
Multiple and Simultaneous Tobacco Use and Other Risk Behaviors Among High School Students 2015 Vermont Youth Risk Behavior Survey
Multiple and Simultaneous Tobacco Use and Other Risk Behaviors Among High School Students 2015 Vermont Youth Risk Behavior Survey Background Simultaneous use of multiple tobacco products is associated with risk factors that include and extend beyond what is typically considered with tobacco use1. While youth cigarette use has fallen consistently the last several decades2, adolescence remains the time at which tobacco use is started and established. Nearly nine in ten smokers start smoking by age 183. Furthermore, simultaneous use of multiple products is common among youth and increases the likelihood of addiction and continuation of smoking into adulthood4. In 2015, the Vermont high school youth risk behavior survey (YRBS) asked students about tobacco use, including use of cigarettes, cigar products, smokeless tobacco, and electronic vapor products. Number of Tobacco Products Used, Last 30 Days Poly Use High School Students, 2015 Overall, about one in ten (12%) high school students 77% used only one type of tobacco in the last month. One in twenty students reported current use of two forms of tobacco (dual use, 6%) and three or more 12% tobacco products (poly use, 5%). Three‐quarters of 6% 5% high school students did not use any tobacco during this time. Male high school students were No Use Single Dual Poly significantly more likely than females to currently use any type of tobacco (27% vs. 19%), and report dual (7% vs. 5%) or poly use (7% vs. 3%) (data not shown). Alcohol and Marijuana Use Alcohol and marijuana use differed by the number of tobacco products used. As the number of tobacco products used increased, so did the prevalence of alcohol and marijuana use. -
Adolescent Drug Terminology and Trends: 2017-18 Edition
Adolescent Drug Terminology and Trends: 2017-18 Edition Matthew Quinn, LCPC, CADC Community Relations Coordinator Vaping Term used to describe when a substance is heated to the point of releasing vapor but not combusted (lit on fire). • Increasing in popularity as a way to ingest nicotine and cannabis, often in an electronic device that looks like a pen • Usually relatively odorless and difficult to distinguish between nicotine and cannabis vape device Juul (pronounced jewel) Specific vaping product from Pax Labs similar to an e- cigarette used to ingest nicotine • Liquid contains nicotine salts extracted from the tobacco leaf (2x nicotine of previous e-cigs) • Variety of flavors • Cool mint • Mango • Crème brule Dabs Dabs is a highly concentrated butane hash oil (BHO) created in a process where high quality cannabis is blasted with butane and extracted. • Heated and inhaled • Contains 70-90% THC compared to 5-15% THC in regular cannabis • Wax, oil, shatter, crumble • Sauce, distillate Rig A rig is a device used to vaporize and inhale dabs. • Looks similar to a water pipe or bong • Usually a nail is heated with a hand- held torch to a high temperature and a small piece of the concentrate is ‘dabbed’ onto a nail • Vapor released is then inhaled through the pipe Edibles • Increasingly popular alternative to smoking marijuana • Produced to infuse marijuana into various ingestible forms • Problem is that effects are hard to predict and difficult to know dose Other Terms for Cannabis • Bud • Dank • Nug • Loud • Fire • Gas Bars (Ladders) Another name for the rectangular shaped Xanax (anti- anxiety medication) with three lines in them (typically 2mg per ‘bar’). -
The Opioid Crisis and the Black/African American Population: an Urgent Issue
THE OPIOID CRISIS AND THE BLACK/AFRICAN AMERICAN POPULATION: AN URGENT ISSUE THE OPIOID CRISIS AND THE BLACK/AFRICAN AMERICAN POPULATION: AN URGENT ISSUE U.S. Department of Health and Human Services Substance Abuse and Mental Health Services Administration Office of Behavioral Health Equity Table of Contents Introduction ...................................................................................................................................................... 3 i. Purpose of the Issue Brief ........................................................................................................................ 3 ii. Sources of Information ............................................................................................................................ 4 Opioids in Black/African American Communities: Context .................................................................. 4 i. What Do the National Data Show? ........................................................................................................ 4 ii. Routes to Opioid Misuse and Overdose Deaths: Pain Management, Illicit Drug Use, and Opioid Comorbidities in Black/African American Communities .................................................... 6 iii. Challenges to Prevention, Treatment, and Recovery .......................................................................... 7 Strategies to Address Opioid Misuse and OUD in Black/African American Communities ............ 9 i. Standard Treatment ................................................................................................................................ -
ADHD: Substance Abuse
1/13/2012 Overview of Mental Health Medications for Children and Adolescents Module 6 Medications and Drugs of Abuse 1 1967 Now Alcohol Alcohol Marijuana Marijuana Cocaine Cocaine Methamphetamine Crank LSD LSD Rohypnol/GHB Quaaludes Inhalants Glue Ecstasy Designer drugs Prescription drugs 2 ADHD: Substance Abuse Children with untreated ADHD are twice as likely to develop substance abuse by age 18-20 than those who were treated Treatment with stimulants in adolescents with ADHD and comorbid substance abuse improves the ADHD and does not worsen the substance abuse disorder 3 1 1/13/2012 Drug Lingo Resources www.noslang.com www.teenchatterdecoder.com 4 2001 2003 2004 2008 Cocaine 967.6 kg 379.6 1308.1 1016.1 kg kg kg Heroin 15.8 kg 60 kg 39.3 kg 3.3 kg Meth 77.4 kg 88 kg 83.9 kg 65 kg Meth Labs 51 226 261 78 Ecstasy Tablets 52951 8393 5 Cocaine Bulk cocaine transported into state – crack made locally Primary sources – Texas and California Heroin Sources of supply – Chicago, New York and Southwest Purity in GA ranges between 52-65% Greater Hispanic involvement www.dea.gov 6 2 1/13/2012 Drug Use in Georgia Methamphetamine Atlanta, Dalton, Gainesville showing increases as well as southwest and eastern counties Increased availability of ICE in Atlanta area Club drugs MDMA, GHB and ketamine readily available (gyms, college campuses and associated ‘hang outs’ LSD usually around school settings – imported from West Coast by US postal service or express mail Emerging trend – ‘candy tripping’ – combining LSD and MDMA -
Phencyclidine: an Update
Phencyclidine: An Update U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES • Public Health Service • Alcohol, Drug Abuse and Mental Health Administration Phencyclidine: An Update Editor: Doris H. Clouet, Ph.D. Division of Preclinical Research National Institute on Drug Abuse and New York State Division of Substance Abuse Services NIDA Research Monograph 64 1986 DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Alcohol, Drug Abuse, and Mental Health Administratlon National Institute on Drug Abuse 5600 Fishers Lane Rockville, Maryland 20657 For sale by the Superintendent of Documents, U.S. Government Printing Office Washington, DC 20402 NIDA Research Monographs are prepared by the research divisions of the National lnstitute on Drug Abuse and published by its Office of Science The primary objective of the series is to provide critical reviews of research problem areas and techniques, the content of state-of-the-art conferences, and integrative research reviews. its dual publication emphasis is rapid and targeted dissemination to the scientific and professional community. Editorial Advisors MARTIN W. ADLER, Ph.D. SIDNEY COHEN, M.D. Temple University School of Medicine Los Angeles, California Philadelphia, Pennsylvania SYDNEY ARCHER, Ph.D. MARY L. JACOBSON Rensselaer Polytechnic lnstitute National Federation of Parents for Troy, New York Drug Free Youth RICHARD E. BELLEVILLE, Ph.D. Omaha, Nebraska NB Associates, Health Sciences Rockville, Maryland REESE T. JONES, M.D. KARST J. BESTEMAN Langley Porter Neuropsychiatric lnstitute Alcohol and Drug Problems Association San Francisco, California of North America Washington, D.C. DENISE KANDEL, Ph.D GILBERT J. BOTV N, Ph.D. College of Physicians and Surgeons of Cornell University Medical College Columbia University New York, New York New York, New York JOSEPH V.